Slider-home

Infectious Diseases and Immunity in Global Health Program

The Infectious Diseases and Immunity in Global Health Program is integrating research in infectious diseases, immunity and global health at the Research Institute of the McGill University Health Centre (RI-MUHC) into work groups with a strong translational focus.

The translational topics are (i) diagnostics, (ii) therapeutics and prevention and (iii) epidemiology and health outcomes. A distinguishing feature of the program are cross-disciplinary research teams encompassing basic biomedical, clinical and health outcomes research that jointly work on novel ways to improve patient well-being and population health in focus diseases.

Program initiatives are well integrated with ongoing research efforts of other groups at McGill University, as well as national and international centres and organizations dedicated to infectious and immune-mediated diseases. This provides the organizational framework for cutting edge research at the front lines of the most pressing global disease threats by programme scientists.

IDIGH Calendar

<<  <  February 2020  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
       1  2
  3  4  5  6  7  8  9
10111213141516
17181920212223
242526272829 

Upcoming Events

Latest IDIGH Publications

  1. Zhang, E., Khanna, V., Dacheux, E., Namane, A., Doyen, A., Gomard, M., Turcotte, B., Jacquier, A. & Fromont-Racine, M.
    (2019)
    .
    A specialised SKI complex assists the cytoplasmic RNA exosome in the absence of direct association with ribosomes
    .
    The EMBO journal
    ,
    vol
    .
    38
    ,
    p
    .
    e100640
    .
  2. Kteily-Hawa, R., Andany, N., Wang, Y., Logie, C. H., Tharao, W., Conway, T., Webster, K., de Pokomandy, A., Kaida, A., Hogg, R., Loutfy, M. & (as senior author) on behalf of the CHIWOS Research Team.
    (2019)
    .
    Quality of life of older women living with HIV: comparative assessment of physical and mental health-related markers using a large Canadian Sexual and Reproductive Health Cohort Study
    .
    HIV research & clinical practice
    ,
    vol
    .
    20
    ,
    p
    .
    35-47
    .
  3. Richards, C., Penner, J., Colmegna, I., Loewen, H., Melaku, Z., Melkie, A., Meltzer, M., Scuccimarri, R., Mengistu, Y. & Hitchon, C. A.
    (2019)
    .
    Methotrexate Exposure and Risk of Strongyloidiasis
    .
    Tropical medicine & international health : TM & IH
  4. Moussa, Y., Sullivan, A., Matte, G., Goldstein, R. H., Baldini, G., Shuster, J. & Tsoukas, C.
    (2019)
    .
    Impact of Persistent Beta-Lactam Allergy Documentation Despite De-Labeling in the Perioperative Setting
    .
    The journal of allergy and clinical immunology. In practice
  5. Rose, K. L., Sherman, P. M., Cooke-Lauder, J., Mawani, M., Benchimol, E. I., Kaplan, G. G., Bernstein, C. N., Bitton, A., Murthy, S. K., Nguyen, G. C. & Lee, K.
    (2019)
    .
    The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada
    .
    Journal of the Canadian Association of Gastroenterology
    ,
    vol
    .
    2
    ,
    p
    .
    S81-S91
    .
More publications